- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Reliance Chemotex has announced a board meeting on August 14, 2025, where it approved the financial results for the quarter ended June 30, 2025.
**1) Revenue Performance:** The company reported a revenue from operations of Rs 92.36 Cr for Q1 FY26, marking a solid 12.36% increase year-over-year from Rs 82.20 Cr in Q1 FY25. The company operates solely in the Yarns segment.
**2) Profitability and EPS:** Despite the revenue growth, net profit for the period saw a significant decline, falling by 42.4% to Rs 1.06 Cr in Q1 FY26 from Rs 1.84 Cr in Q1 FY25. Earnings per share (EPS) also decreased from Rs 2.44 to Rs 1.41. Profit Before Tax margin compressed sharply from 3.61% to 1.03%.
**3) Operational Costs:** Total expenses rose to Rs 91.80 Cr in Q1 FY26 from Rs 80.90 Cr in Q1 FY25, outpacing revenue growth. Notably, finance costs increased by 11.5%, and a substantial drop in other income (from Rs 1.72 Cr to Rs 0.39 Cr) significantly impacted the bottom line.
**7) Final Takeaway:** While the company showed good top-line expansion, the sharp decline in profitability signals weak momentum. This was primarily driven by rising operational costs and reduced other income. Investors should closely monitor expense management and the stability of other income streams.